负载pVAX1-wapA的壳聚糖及季铵化壳聚糖纳米粒的制备研究

向婧洁; 钟延强; 陆一鸣; 鲁莹

doi:10.3969/j.issn.1006-0111.2016.01.006

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

负载pVAX1-wapA的壳聚糖及季铵化壳聚糖纳米粒的制备研究

向婧洁, 钟延强, 陆一鸣, 鲁莹

文章导航 > 药学实践与服务 > 2016 > 34(1): 19-23,40

向婧洁, 钟延强, 陆一鸣, 鲁莹. 负载pVAX1-wapA的壳聚糖及季铵化壳聚糖纳米粒的制备研究[J]. 药学实践与服务, 2016, 34(1): 19-23,40. doi: 10.3969/j.issn.1006-0111.2016.01.006

引用本文:

XIANG Jingjie, ZHONG Yanqiang, LU Yiming, LU Ying. Preparation of DNA-loaded chitosan nanoparticle vaccine[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(1): 19-23,40. doi: 10.3969/j.issn.1006-0111.2016.01.006

Citation:

XIANG Jingjie, ZHONG Yanqiang, LU Yiming, LU Ying. Preparation of DNA-loaded chitosan nanoparticle vaccine[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(1): 19-23,40. doi: 10.3969/j.issn.1006-0111.2016.01.006

负载pVAX1-wapA的壳聚糖及季铵化壳聚糖纳米粒的制备研究

doi: 10.3969/j.issn.1006-0111.2016.01.006

第二军医大学药学院, 上海 200433

Preparation of DNA-loaded chitosan nanoparticle vaccine

School of Pharmacy, Second Military Medical University, Shanghai 200433, China

摘要: 目的制备负载抗龋DNA疫苗pVAX1-wapA质粒的壳聚糖和季铵化壳聚糖纳米粒,优化其制备工艺,测定其细胞转染效率。方法以包封率和粒径为主要指标,单因素法考察载体浓度、pH值、N/P、TPP浓度等因素的影响,Realtime-PCR检测细胞对质粒编码蛋白的转录表达水平以评价载质粒纳米粒的促转染作用。结果制得的载DNA疫苗纳米粒粒径均一,形态圆整。壳聚糖(CS)纳米粒粒径为(219.2±18.2) nm,Zeta电位为(24.7±3.5) mV,包封率为91.24%。季铵化壳聚糖(CSTM)纳米粒粒径为(222.5±15.6) nm,Zeta电位为(19.6±1.2) mV,包封率为87.66%。纳米粒可以促进pVAX1-wapA进入细胞,并成功被转录。结论制备的包载pVAX1-wapA的季铵化壳聚糖纳米粒可用于重组基因疫苗的运送。
- DNA疫苗 /
- 壳聚糖纳米粒 /
- wapA蛋白 /
- 转染 /
- 季铵化壳聚糖
Abstract: Objective To study and optimize the preparation condition of pVAX1-wapA-loaded nanoparticles and determine the transfection efficiency. Methods The related effects of the crucial factors for the formation of nanoparticles: concentration of chitosan and TPP, pH value, N/P ratio were studied by single-factor experiment, with nanoparticles size and zeta potential as index. Cell transfection test was carried out to indicate that enhancement of cell transfection efficiency of nano-carrier. Results Nanoparticles loaded DNA vaccine were nearly spherical shape with uniform particle size chitosan nanoparticle(CS),(219.2±18.2) nm;quaternary ammonium chitosan nanoparticles(CSTM),(222.5±15.6) nm. Zeta potential of CS and CSTM was (24.7±3.5) mV, (19.6±1.2) mV and encapsulation efficiency was 91.24%, 87.66%,respectively.CSTM nanoparticle could enhance cellular uptake of pVAX1-wapA obviously. Conclusion CSTM nanoparticle was proved to be an efficient DNA vaccine delivery vector.
- DNA vaccine /
- chitosan nanoparticle /
- wapA protein /
- transfection /
- quaternary ammonium chitosan

[1]	樊明文,边专. 防龋疫苗主动免疫的现状与未来[J]. 中华口腔医学杂志, 2002,37(6):401-403.
[2]	刘善奎,高申,钟延强,等. DNA 疫苗微球给药系统的研究进展[J]. 中国药学杂志,2004,38(11):828-831.
[3]	白枫,孙大庆. DNA疫苗递送系统研究进展[J]. 国际免疫学杂志,2008,31(3):236-239.
[4]	李艳红,胡四海. 壳聚糖纳米粒介导基因转染的影响因素及改性修饰[J]. 微生物学免疫学进展,2010,38(3):50-53.
[5]	Erbacher P,Zou S, Bettinger T,et al. Chitosan-based vector/DNA complexes for gene delivery: Biophysical Characteristics and Transfection Ability[J].Pharm Res,1998,15(9):1332-1339.
[6]	Lee M,Nah JW,Kwon Y,et al. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery[J]. Pharm Res,2001,18(4):427-431.
[7]	Ishii T,Okahata Y,Sato T. Mechanism of cell transfection with plasmid/chitosan complexes[J]. Biochim Biophys Acta,2001,1514(1):51-64.
[8]	Huang M,Fong CW,Khor E,et al. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation[J]. J Control Release,2005,106(3):391-406.
[9]	杨晓容,宗莉,朱敏艳,等. 荧光探针示踪pDNA/壳聚糖纳米粒在细胞内转运[J].中国药学杂志,2009,43(10):727-731.
[10]	王江峰,鲁莹,黄景彬,等.聚氨基酯载基因纳米粒的研究[J].第二军医大学学报,2011,32(5):473-476.
[11]	Qian F,Cui F,Ding J,et al. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization[J].Biomacromolecules,2006,7(10):2722-2727.
[12]	刘世伟，孙逊，聂宇，等。载基因壳聚糖纳米粒的制备及其相关性质的初步研究[J].华西药学杂志，2005,19 (6):409-411.
[13]	Mao HQ,Roy K,Troung-Le VL,et al.Chitosan-DNA nano-particles as gene carriers: synthesis, characterization and transfection efficiency [J]. J Control Release,2001,70 (3): 399-421.
[14]	Goldmann K,Ensminger SM,Spriewald BM.Oral gene appli-cation using chitosan-DNA nanoparticles induces transferable tolerance[J].Clin Vaccine Immunol,2012,19 (11):1758-1764.

点击查看大图

计量

文章访问数: 3162
HTML全文浏览量: 217
PDF下载量: 131
被引次数: 0

负载pVAX1-wapA的壳聚糖及季铵化壳聚糖纳米粒的制备研究

doi: 10.3969/j.issn.1006-0111.2016.01.006

第二军医大学药学院, 上海 200433

收稿日期: 2015-08-24
修回日期: 2015-11-16

关键词:

DNA疫苗 /

壳聚糖纳米粒 /

wapA蛋白 /

转染 /

季铵化壳聚糖

摘要: 目的制备负载抗龋DNA疫苗pVAX1-wapA质粒的壳聚糖和季铵化壳聚糖纳米粒,优化其制备工艺,测定其细胞转染效率。方法以包封率和粒径为主要指标,单因素法考察载体浓度、pH值、N/P、TPP浓度等因素的影响,Realtime-PCR检测细胞对质粒编码蛋白的转录表达水平以评价载质粒纳米粒的促转染作用。结果制得的载DNA疫苗纳米粒粒径均一,形态圆整。壳聚糖(CS)纳米粒粒径为(219.2±18.2) nm,Zeta电位为(24.7±3.5) mV,包封率为91.24%。季铵化壳聚糖(CSTM)纳米粒粒径为(222.5±15.6) nm,Zeta电位为(19.6±1.2) mV,包封率为87.66%。纳米粒可以促进pVAX1-wapA进入细胞,并成功被转录。结论制备的包载pVAX1-wapA的季铵化壳聚糖纳米粒可用于重组基因疫苗的运送。